Türker Bilgen

529 total citations
32 papers, 355 citations indexed

About

Türker Bilgen is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Türker Bilgen has authored 32 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 10 papers in Hematology and 9 papers in Molecular Biology. Recurrent topics in Türker Bilgen's work include Hemoglobinopathies and Related Disorders (8 papers), Iron Metabolism and Disorders (6 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Türker Bilgen is often cited by papers focused on Hemoglobinopathies and Related Disorders (8 papers), Iron Metabolism and Disorders (6 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Türker Bilgen collaborates with scholars based in Türkiye and Finland. Türker Bilgen's co-authors include Güven Lüleci, İbrahim Keser, Özgür Tosun, I Keser, Tapio Visakorpi, Jukka Westermarck, Özgül M. Alper, Zehra Güven Çetin, Hakan Erengin and Necati Dedeoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Medicine.

In The Last Decade

Türker Bilgen

31 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Türker Bilgen Türkiye 10 118 76 65 59 55 32 355
Suzanne Monjanel‐Mouterde France 13 55 0.5× 109 1.4× 37 0.6× 76 1.3× 92 1.7× 22 408
Yusuke Hara Japan 11 193 1.6× 78 1.0× 32 0.5× 61 1.0× 28 0.5× 30 383
Janel Long‐Boyle United States 8 69 0.6× 28 0.4× 65 1.0× 26 0.4× 137 2.5× 17 312
Chirag G. Patel United States 10 179 1.5× 92 1.2× 27 0.4× 27 0.5× 36 0.7× 13 361
Marie-Noëlle Peraldi France 9 72 0.6× 20 0.3× 22 0.3× 22 0.4× 50 0.9× 10 402
Dion Chen United States 8 52 0.4× 35 0.5× 26 0.4× 77 1.3× 46 0.8× 9 357
María Santos Spain 11 219 1.9× 113 1.5× 12 0.2× 39 0.7× 103 1.9× 20 500
Joanna Peng United States 12 77 0.7× 88 1.2× 31 0.5× 12 0.2× 20 0.4× 14 404
Hongbing Huang China 9 169 1.4× 124 1.6× 15 0.2× 31 0.5× 48 0.9× 24 383
Eija Tukiainen Finland 10 38 0.3× 70 0.9× 16 0.2× 18 0.3× 13 0.2× 19 360

Countries citing papers authored by Türker Bilgen

Since Specialization
Citations

This map shows the geographic impact of Türker Bilgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Türker Bilgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Türker Bilgen more than expected).

Fields of papers citing papers by Türker Bilgen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Türker Bilgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Türker Bilgen. The network helps show where Türker Bilgen may publish in the future.

Co-authorship network of co-authors of Türker Bilgen

This figure shows the co-authorship network connecting the top 25 collaborators of Türker Bilgen. A scholar is included among the top collaborators of Türker Bilgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Türker Bilgen. Türker Bilgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bilgen, Türker, et al.. (2025). The effects of liraglutide on expressions of insulin secretion and beta cell survive associated GPCR genes in pancreatic beta cells. TURKISH JOURNAL OF MEDICAL SCIENCES. 55(2). 525–530. 1 indexed citations
2.
Muz, Dilek, Berna Erdal, Türker Bilgen, et al.. (2024). Myxoma Virus Combination Therapy Enhances Lenalidomide and Bortezomib Treatments for Multiple Myeloma. Pathogens. 13(1). 72–72. 2 indexed citations
3.
Bilgen, Türker, et al.. (2024). Investigation of the Effects of Piperlongumine and Doxorubicin Combined Treatment on Cell Death via PTEN in HeLa Cells. DergiPark (Istanbul University). 29(1). 1–11.
4.
Doğuer, Çağlar, et al.. (2022). Protective effects of Acetobacter ghanensis against gliadin toxicity in intestinal epithelial cells with immunoregulatory and gluten-digestive properties. European Journal of Nutrition. 62(2). 605–614. 4 indexed citations
5.
Ata, Pınar, et al.. (2022). Alloreactive memory B cell detection by flow cytometric cross match using polyclonally activated memory B cell culture supernatants. Transplant Immunology. 73. 101642–101642. 1 indexed citations
6.
Keser, İbrahim, et al.. (2021). Investigation of Alpha Globin Gene Mutations by Complementary Methods in Antalya. Eastern Journal Of Medicine. 26(1). 117–122. 2 indexed citations
7.
Bilgen, Türker, et al.. (2020). Piperlongumine increases the apoptotic effect of doxorubicin and paclitaxel in a cervical cancer cell line. Nigerian Journal of Clinical Practice. 23(3). 386–386. 17 indexed citations
8.
Bilgen, Türker, et al.. (2020). Why Crossmatch Tests are Very Important and What Do They Tell Us?. 29(1). 77–81. 1 indexed citations
9.
Bilgen, Türker, et al.. (2019). Genetic alterations of C9orf72, SOD1, TARDBP, FUS, and UBQLN2 genes in patients with Amyotrophic Lateral Sclerosis. SHILAP Revista de lepidopterología. 6(1). 1582400–1582400. 6 indexed citations
10.
11.
Bilgen, Türker, et al.. (2016). A Novel Mutation in the Promoter Region of theβ-Globin Gene:HBB: c.-127G > C. Hemoglobin. 40(4). 280–282. 1 indexed citations
12.
13.
Akman, Sema, et al.. (2012). Prevalence and significance of the MEFV gene mutations in childhood Henoch–Schönlein purpura without FMF symptoms. Rheumatology International. 33(2). 377–380. 26 indexed citations
14.
Khanna, Anchit, Juha Okkeri, Türker Bilgen, et al.. (2011). ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells. PLoS ONE. 6(3). e17979–e17979. 51 indexed citations
15.
Bilgen, Türker, et al.. (2011). The association between intragenic SNP haplotypes and mutations of the beta globin gene in a Turkish population. Blood Cells Molecules and Diseases. 46(3). 226–229. 13 indexed citations
16.
Bilgen, Türker, et al.. (2010). The effect of CYP1A2 gene polymorphisms on Theophylline metabolism and chronic obstructive pulmonary disease in Turkish patients. BMB Reports. 43(8). 530–534. 23 indexed citations
17.
Mendilcioğlu, İnanç, et al.. (2010). The association between inherited thrombophilias and pregnancy-related hypertension recurrence. Archives of Gynecology and Obstetrics. 284(4). 837–841. 8 indexed citations
18.
Şimşek, Mehmet, Zafer Çetin, Türker Bilgen, et al.. (2007). Effects of hormone replacement therapy on bone mineral density in Turkish patients with or without COL1A1 Sp1 binding site polymorphism. Journal of obstetrics and gynaecology research. 34(1). 73–77. 17 indexed citations
19.
Akbaş, S. Halide, Türker Bilgen, I Keser, et al.. (2006). The Effect of MDR1 (ABCB1) Polymorphism on the Pharmacokinetic of Tacrolimus in Turkish Renal Transplant Recipients. Transplantation Proceedings. 38(5). 1290–1292. 39 indexed citations
20.
Alper, Özgül M., Hakan Erengin, Türker Bilgen, et al.. (2003). Consanguineous marriages in the province of Antalya, Turkey. Annales de Génétique. 47(2). 129–138. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzanne Monjanel‐Mouterde Breakdown of academic impact, for papers by Yusuke Hara Breakdown of academic impact, for papers by Janel Long‐Boyle Breakdown of academic impact, for papers by Chirag G. Patel Breakdown of academic impact, for papers by Marie-Noëlle Peraldi Breakdown of academic impact, for papers by Dion Chen Breakdown of academic impact, for papers by María Santos Breakdown of academic impact, for papers by Joanna Peng Breakdown of academic impact, for papers by Hongbing Huang Breakdown of academic impact, for papers by Eija Tukiainen
Rankless by CCL
2026